Navigation Links
Erika Schwartz MD Congratulates Oprah Winfrey for Spotlighting Bioidentical Hormones
Date:1/15/2009

For now, she says: "Let's just celebrate the fact that bioidentical hormones are coming out and are finally being considered as viable treatments for feeling lousy. No longer are we hearing that bioidenticals are just a marketing term. Now that is progress!

New York, NY (PRWEB) January 15, 2009 -- Today is a big day for women's health and bioidentical hormones, says Erika Schwartz MD in her latest blog at www.derika.com.

For the first time, she says, mainstream media is acknowledging that women are suffering unnecessarily and that hormone imbalance is an overwhelming handicap that needs attention and legitimate treatments. It can no longer be swept under the rug.

Dr. Erika notes it took someone like Oprah Winfrey, who is suffering from inadequately treated thyroid problems, menopausal hormone loss and its attendant weight gain to blast the hinges off the door to bioidentical hormone therapy.

Acknowledgement is always the precursor to enlightenment, she adds.

Dr. Erika says she hopes Oprah will consider bioidenticals an important ingredient in her commitment to achieving true wellness.

For now, she says: "Let's just celebrate the fact that bioidentical hormones are coming out and are finally being considered as viable treatments for feeling lousy. No longer are we hearing that bioidenticals are just a marketing term. Now that is progress!

"The next step involves educating the medical community about the existence of bioidenticals, providing them with the studies about them, teaching them the difference between how bioidenticals and non-identical hormone molecules work in the human body and making sure they know that bioidenticals are FDA approved and available at your local drugstore."

Dr. Erika says doctors also need to understand the role and usefulness of compounding pharmacies and get involved with who compounds the hormones they prescribe.

Finally, Dr. Erika says, balanced and honest studies must be undertaken on a large scale and in full view that compare the efficacy and safety of bioidenticals to their non-identical counterparts. The era of creating confusion and muddying the waters of hormone therapies has reached its end.

DrErika.com is dedicated to providing an independent, honest view on healthcare topics and issues from a position of devoted patient advocacy.

Its founder, Erika Schwartz MD, is an internationally-recognized patient advocate, practicing physician, expert in conventional and integrative medicine, author of four books and a frequent guest on TV and radio. DrErika.com doesn't tailor its stories to suit sponsors - it does not accept sponsors.

# # #

Read the full story at http://www.prweb.com/releases/2009/01/prweb1872574.htm


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Anapol Schwartz Attorney Representing Trasylol(R) Victims Says Medical Study - Confirming Heart Bypass Drug Mortality Risk - to Open Floodgates for More Litigation
2. Steve and Paula Mae Schwartz Honored With Publicity Club of New Englands Crystal Bell Award
3. SAND Technology Appoints Zainab Ahmed Schwartz as CFO
4. The Kenneth B. Schwartz Center, ASTRO partner to raise awareness of cancer survivorship
5. Anapol Schwartz Attorney Named to Executive Committee of American Association for Justice
6. Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award
7. American Heart Association Congratulates Pioneer Heart Surgeon for Being Named Recipient of Congressional Gold Medal Award
8. Mission Pharmacal Congratulates Exemplary Womens Health Researchers
9. Internet2 Congratulates FCC Rural Health Care Pilot Program Grant Awardees
10. SNM congratulates NOPR and its supporting organizations on successful conclusion of project
11. Coalition for 21st Century Medicine Congratulates U.S. Senate on Passage of Genetic Information Nondiscrimination Act
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... While it’s ... poses a problem. Fortunately, an inventor from Austin, Texas, has identified a solution. , ... medication in darkness or restricted lighting. As such, it eliminates the need to turn ...
(Date:10/13/2017)... , ... October 13, 2017 , ... PurhealthRX , ... Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize ... providing a CBD form that can be easily incorporated into liquid products, while reducing ...
(Date:10/13/2017)... Shelton, CT (PRWEB) , ... October 13, 2017 , ... ... and long-term care services, staged a mock evacuation of the facility as part of ... Department, Shelton Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well ...
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... be giving viewers the lowdown on sciatica in a new episode of "Success ... focuses on current events and innovation and investigates each subject in-depth with passion ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/19/2017)... 19, 2017   ZirMed Inc ., a recognized leader ... that it has been ranked #1 by its users for ... Rankings 2017 User Survey. ZirMed was recognized as the top-ranked ... and medical centers over 200 beds and holds one of ... user survey history. ...
(Date:9/12/2017)... PARIS and NEW YORK , Sept. 12, ... ethical performance ratings for global supply chains, has published the first annual ... the CSR performance of more than 20,400 companies evaluated by EcoVadis, based ... years 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
Breaking Medicine Technology: